Suchergebnisse - "Xu, Yanjun"

PubPharm (448)

21

Pharmaceutical composition containing favipiravir as well as preparation method and application thereof

enthalten in: Europäisches Patentamt | 2023

von ZHANG YINLONG | LI WEI | JIN ZHENSHI | +4

22

Pharmaceutical composition containing favipiravir as well as preparation method and application thereof

enthalten in: Europäisches Patentamt | 2023

von ZHANG YINLONG | LI WEI | JIN ZHENSHI | +4

23

Sintilimab plus anlotinib as second- or third-line therapy in metastatic non-small cell lung cancer with uncommon epidermal growth factor receptor mutations : A prospective, single-arm, phase II trial

enthalten in: Cancer medicine | 2023

von Chen, K. | Xu, Y. | Huang, Z. | +9

24

CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules

enthalten in: Scientific reports | 2023

von Feng, S. | Yuan, S. | Hou, B. | +4

25

Erratum : Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA' [Acta Pharmaceutica Sinica B 13 (2023) 2585-2600

enthalten in: Acta pharmaceutica Sinica. B | 2023

von Zhang, W. | Pan, X. | Xu, Y. | +8

ErratumFor: Acta Pharm Sin B. 2023 Jun;13(6):2585-2600. - PMID 37425040

26

Comprehensive analyses of brain cell communications based on multiple scRNA-seq and snRNA-seq datasets for revealing novel mechanism in neurodegenerative diseases

enthalten in: CNS neuroscience & therapeutics | 2023

von Zhang, C. | Tan, G. | Zhang, Y. | +9

27

Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer : An open-label, single-arm, multicenter study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Xu, Y. | Huang, Z. | Chang, J. | +10

28

Pharmaceutical composition for treating cancer

enthalten in: Europäisches Patentamt | 2023

von XU YANJUN | LI JIAKUI

29

Pharmaceutical composition for treating cancer

enthalten in: Europäisches Patentamt | 2023

von XU YANJUN | LI JIAKUI

30

Refining method of favipiravir and/or derivatives thereof

enthalten in: Europäisches Patentamt | 2023

von DENG SHENGJU | TSENG EN-YU | LI CHENGLIN | +4